This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
World Health Organization. Cardiovascular diseases (CVDs) Factsheet N° 316. [online], (2013).
Datamonitor Healthcare. Epidemiology: Dyslipidemia (December 2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Hudson, V. The dyslipidaemia market. Nat Rev Drug Discov 13, 807–808 (2014). https://doi.org/10.1038/nrd4475
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4475
This article is cited by
-
PCSK9 Inhibitors’ New Users: Analysis of Prescription Patterns and Patients’ Characteristics from an Italian Real-world Study
Clinical Drug Investigation (2020)